| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-11 |
| mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
9e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
| mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |